Douglas Jermasek

EVP of Corporate Strategy, Unicycive Therapeutics, Inc.

Companies

Unicycive Therapeutics, Inc.EVP of Corporate Strategy Nov 23, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Unicycive Therapeutics, Inc. UNCY175,012 shares²$630.0K at $3.60Jul 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 11, 2023Exercised options 104,612 shares of Unicycive Therapeutics, Inc.²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARUnicycive Therapeutics, Inc., EVP of Corporate Strategy
2
SEC EDGARUnicycive Therapeutics, Inc. shares after the filing of Jul 11, 2023